Your browser doesn't support javascript.
loading
Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis.
Moradi, Luke A; Clark, Curtis A; Schneider, Craig S; Deshane, Alok S; Dobelbower, Michael C.
Afiliação
  • Moradi LA; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Clark CA; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Schneider CS; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
  • Deshane AS; Case Western Reserve University School of Medicine, Cleveland, OH, United States.
  • Dobelbower MC; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
Front Immunol ; 12: 788499, 2021.
Article em En | MEDLINE | ID: mdl-34956219

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Prednisona / Colite / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Inibidores de Checkpoint Imunológico / Imunossupressores / Melanoma / Miastenia Gravis Tipo de estudo: Diagnostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Prednisona / Colite / Anticorpos Monoclonais Humanizados / Quimiorradioterapia / Inibidores de Checkpoint Imunológico / Imunossupressores / Melanoma / Miastenia Gravis Tipo de estudo: Diagnostic_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article